I also think that eventually there will be a better FTO inhibitor, so our critical advantage is our head start in getting to market. we need to keep cracking on at pace
Dr T made it clear any FTO competitors are years behind in terms of development and research and trials. Not to mention the tens or hundreds of millions in development of a new compound.
IMO I doubt waiting 6 or 9 months (from late this year to mid 2022) will have a risk of a competitor.
What's going on with Race Oncology at the moment ?, page-52
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
-0.050(2.98%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.68 | $1.61 | $46.61K | 28.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1325 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 1947 | 1 |
View Market Depth
| Last trade - 11.33am 04/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |